N Hadiji1, J G Previnaire2, R Benbouzid1, G Robain3, C Leblond1, R Mieusset4, M Enjalbert5, J M Soler1. 1. Centre Bouffard-vercelli-Laboratoire de neuro-urologie et de sexologie, Cerbère, France. 2. Département médullaire, centre Calvé, Fondation Hopale, Berck-Sur-Mer, France. 3. AP-HP Hôpital Rothschild-Unité fonctionnelle de Médecine physique et de Réadaptation, Paris, France. 4. CECOS- Hôpital Paule de Viguier, Toulouse, France. 5. 1] Centre Bouffard-vercelli-Laboratoire de neuro-urologie et de sexologie, Cerbère, France [2] Centre Hospitalier de Perpignan, Perpignan, France.
Abstract
OBJECTIVES: To evaluate the efficacy of anticholinergic agents in the treatment of neurogenic overactive bladder (NOAB) and neurogenic detrusor overactivity (NDO) in spinal cord injury (SCI) patients on clean intermittent catheterisation (CIC). METHODS: Chronic suprasacral SCI patients on CIC presenting with at least one urinary leakage a day were included. Urodynamics and voiding diaries were performed at baseline and 1 month follow-up. In case of NDO at baseline, an anticholinergic drug was prescribed. RESULTS: The 231 SCI patients presented with one to five urinary leakages per day (mean 2.1). Urodynamics showed NDO in all patients. A new anticholinergic treatment was started in all, either in monotherapy (134 patients) or in association with the existing anticholinergic drug (oxybutynin+trospium bitherapy, 97 patients). The mean maximum bladder capacity significantly increased from 225 to 441 ml, and the mean involuntary detrusor contractions (IDC) significantly decreased from 67 to 41 cm H2O. Only 75 SCI patients (32%) were fully continent. However, 25 out of these 75 patients showed persistent NDO, with amplitudes of IDC above 40 cm H2O in 12 patients. Incontinence was still found in 156 SCI patients (67%), with an average of 1,2 leakages a day. In 100 patients, amplitudes of IDC remained above 40 cm H2O. There was no statistical difference between patients on anticholinergic monotherapy or bitherapy at follow-up. CONCLUSION: Anticholinergic treatment is not always satisfactory in terms of control of NDO and rarely allows full continence. Urodynamic follow-up is mandatory in all patients, even in those showing clinical continence.
OBJECTIVES: To evaluate the efficacy of anticholinergic agents in the treatment of neurogenic overactive bladder (NOAB) and neurogenic detrusor overactivity (NDO) in spinal cord injury (SCI) patients on clean intermittent catheterisation (CIC). METHODS:Chronic suprasacral SCIpatients on CIC presenting with at least one urinary leakage a day were included. Urodynamics and voiding diaries were performed at baseline and 1 month follow-up. In case of NDO at baseline, an anticholinergic drug was prescribed. RESULTS: The 231 SCI patients presented with one to five urinary leakages per day (mean 2.1). Urodynamics showed NDO in all patients. A new anticholinergic treatment was started in all, either in monotherapy (134 patients) or in association with the existing anticholinergic drug (oxybutynin+trospium bitherapy, 97 patients). The mean maximum bladder capacity significantly increased from 225 to 441 ml, and the mean involuntary detrusor contractions (IDC) significantly decreased from 67 to 41 cm H2O. Only 75 SCI patients (32%) were fully continent. However, 25 out of these 75 patients showed persistent NDO, with amplitudes of IDC above 40 cm H2O in 12 patients. Incontinence was still found in 156 SCI patients (67%), with an average of 1,2 leakages a day. In 100 patients, amplitudes of IDC remained above 40 cm H2O. There was no statistical difference between patients on anticholinergic monotherapy or bitherapy at follow-up. CONCLUSION: Anticholinergic treatment is not always satisfactory in terms of control of NDO and rarely allows full continence. Urodynamic follow-up is mandatory in all patients, even in those showing clinical continence.
Authors: Dennis J Bourbeau; Graham H Creasey; Steven Sidik; Steven W Brose; Kenneth J Gustafson Journal: J Spinal Cord Med Date: 2017-02-15 Impact factor: 1.985
Authors: Claire Doyle; Vivian Cristofaro; Bryan S Sack; Stefan N Lukianov; Mattias Schäfer; Yeun Goo Chung; Maryrose P Sullivan; Rosalyn M Adam Journal: Sci Rep Date: 2017-03-15 Impact factor: 4.379
Authors: C Hui; X Keji; J Chonghe; T Ping; O Rubiao; Z Jianweng; D Xiangrong; Z Liling; H Maping; L Qingqing; L Qiuling; H Jiebing; H Tanghai Journal: Spinal Cord Date: 2015-08-11 Impact factor: 2.772